Intervention not reported
Depression Post‐treatment Lower scores indicate lower levels of depression · children or adolescents with headaches
1 finding from 1 review
Intervention not reported
Anxiety Post‐treatment Lower scores indicate lower levels of anxiety · children or adolescents with headaches
1 finding from 1 review
Intervention not reported
Pain intensity Post‐treatment Lower scores indicate lower levels of pain intensity · children or adolescents with mixed chronic pain conditions
1 finding from 1 review
Intervention not reported
Pain: 50% reduction in headache frequency Post‐treatment Lower scores = fewer headaches · Children and adolescents with chronic pain
It is very uncertain whether the intervention changes pain: 50% reduction in headache frequency Post‐treatment Lower… (very low certainty).
1 finding from 1 review
Intervention not reported
Disability Post‐treatment Lower scores = lower reported disability · Children and adolescents with chronic pain
1 finding from 1 review
Intervention not reported
Anxiety Post‐treatment Lower scores = lower reported anxiety · Children and adolescents with chronic pain
1 finding from 1 review
Intervention not reported
Depression Post‐treatment Lower scores = lower reported depression · Children and adolescents with chronic pain
1 finding from 1 review
Intervention not reported
Disability Post‐treatment Lower scores = lower reported disability · Children and adolescents with chronic pain
1 finding from 1 review
Intervention not reported
Anxiety Post‐treatment Lower scores = lower reported anxiety · Children and adolescents with chronic pain
1 finding from 1 review
Intervention not reported
Depression Post‐treatment Lower scores = lower reported depression · Children and adolescents with chronic pain
1 finding from 1 review
Intervention not reported
Pain Post‐treatment Lower scores = lower reported pain intensity · Children and adolescents with chronic pain
1 finding from 1 review
Proportion of patients who have no AOM recurrences at 6 months post‐randomisation
Grommets may leads to higher proportion of patients who have no AOM recurrences at 6 months… compared with active monitoring (low certainty).
1 finding from 1 review
Total number of AOM recurrences at 6 months post‐randomisation
It is very uncertain whether grommets changes total number of AOM recurrences at 6 months post‐randomisation compared with placebo medication (very low certainty).
1 finding from 1 review
Proportion of patients who have no AOM recurrences at 12 months post‐randomisation
Grommets showed no clear difference in proportion of patients who have no AOM recurrences at 12 months… compared with active monitoring (low certainty).
1 finding from 1 review
Total number of AOM recurrences at 6 months post‐randomisation
Grommets showed no clear difference in total number of AOM recurrences at 6 months post‐randomisation compared with active monitoring (low certainty).
1 finding from 1 review
Total number of AOM recurrences at 12 months post‐randomisation
1 finding from 1 review
Disease‐specific quality of life
1 finding from 1 review
Proportion of patients who have no AOM recurrences at 6 months post‐randomisation
It is very uncertain whether grommets changes proportion of patients who have no AOM recurrences at 6 months… compared with antibiotic prophylaxis (very low certainty).
1 finding from 1 review
Total number of AOM recurrences at 6 months post‐randomisation
It is very uncertain whether grommets changes total number of AOM recurrences at 6 months post‐randomisation compared with antibiotic prophylaxis (very low certainty).
1 finding from 1 review
Proportion of patients who have no AOM recurrences at 6 months post‐randomisation
It is very uncertain whether grommets changes proportion of patients who have no AOM recurrences at 6 months… compared with placebo medication (very low certainty).
1 finding from 1 review